Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Endra Life Sciences Inc (NQ: NDRA )

3.320 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 3.320
Bid (Size) 3.010 (1)
Ask (Size) 5.310 (2)
Prev. Close 3.320
Today's Range 3.320 - 3.320
52wk Range 3.159 - 12.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 14, 2023
From ENDRA Life Sciences Inc.
Via Business Wire

Performance

YTD
-21.88%
-21.88%
1 Month
-8.79%
-8.79%
3 Month
-29.81%
-29.81%
6 Month
-51.18%
-51.18%
1 Year
-56.32%
-56.32%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
ENDRA Life Sciences: Q2 Earnings Insights
Via Benzinga
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
From ENDRA Life Sciences Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Scheduled For November 14, 2022
Via Benzinga
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences
From ENDRA Life Sciences Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
Earnings Scheduled For August 15, 2022
Via Benzinga
Preview: ENDRA Life Sciences Earnings
Via Benzinga
ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
From ENDRA Life Sciences Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.